Study of Magrolimab in Patients With Solid Tumors
Stopped early · Phase 2
Conditions studied: Solid Tumor
In brief
The goals of this clinical study are to learn about the safety, tolerability, dosing and effectiveness of magrolimab in combination with docetaxel in participants with solid tumors.
Key facts
- Study ID
- NCT04827576
- Run by
- Gilead Sciences
- People needed
- 106
- Starts
- 2021-10-01
- Expected to finish
- 2024-10-01
- Last updated by the study team
- 2025-05-08
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Cancer Treatment Centers of America — Goodyear, Arizona, United States
- UC San Diego Moores Cancer Center — La Jolla, California, United States
- Providence Saint John's Health Center — Santa Monica, California, United States
- St. Jude Hospital Yorba dba St. Joseph Heritage Healthcare — Santa Rosa, California, United States
- University of Miami — Deerfield Beach, Florida, United States
- Tallahassee Memorial Healthcare Cancer Center — Tallahassee, Florida, United States
- University Center and Blood Center,LLC. — Athens, Georgia, United States
- Southeastern regional Medical Center — Newnan, Georgia, United States
- Saint Alphonsus Cancer Institute Caldwell — Caldwell, Idaho, United States
- Orchard Healthcare Research Inc — Skokie, Illinois, United States
- University of Iowa Hospitals & Clinics — Iowa City, Iowa, United States
- University of Michigan — Ann Arbor, Michigan, United States
- Virginia Piper Cancer Center (Alliant Health) — Saint Paul, Minnesota, United States
- Comprehensive Cancer Centers of Nevada- Twain Office — Las Vegas, Nevada, United States
- Astera Cancer Care — East Brunswick, New Jersey, United States
- Oregon Health & Science University — Portland, Oregon, United States
- Charleston Oncology — Charleston, South Carolina, United States
- Mary Crowley Cancer Research — Dallas, Texas, United States
- MD Anderson Cancer Center — Dallas, Texas, United States
- Huntsman Cancer Institute, University of Utah — Salt Lake City, Utah, United States
- Medical Oncology Associates,PS (dba Summit Cancer Center) (includes IP Shipment) — Spokane, Washington, United States
- Institut Bergonie — Bordeaux, France
- Centre Georges François Leclerc — Dijon, France
- Centre Hospitalier Regional Universitaire de Lille — Lille, France
- Centre LÃon BÃrard Centre RÃgional de Lutte Contre Le Cancer — Lyon, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.